Role of T lymphocytes in the aetiology of insulin-dependent diabetes

Frontiers of Hormone Research

Volumn 22, Issue , 1997, Pages 90-108

  Peakman, Mark ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344227327     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (85)

1. Gepts W: The pathology of the pancreas in human diabetes; in Andreani D, Di Mario U, Federlin KF, Heding LG (eds): Immunology in Diabetes. London, Kimpton Medical, 1984, pp 21-34.
2. Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble R: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353-360.
3. Hänninen A, Jalkanen S, Salmi M, Toikannen S, Nikolakaros G, Simell O: Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin dependent diabetes mellitus. J Clin Invest 1992;90:1901-1910.
4. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras M-T, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Borrell R: Pancreas in recent-onset insulin dependent diabetes mellitus: Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage and cytokine profile. J Immmunol 1994;153:1360-1377.
5. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y: Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993;92:2313-2322.
6. Sibley RK, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso and allograft: A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985;53:132-144.
7. Santamaria P, Lewis C, Jessurun J, Sutherland DER, Barbosa JJ: Skewed T-cell receptor usage junctional and heterogeneity among isletitis αβ and γδ T-cells in human IDDM. Diabetes 1994;43:599-606.
8. Foulis AK, Farquharson MA, Hardman R: Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:333-343.
9. Foulis AK, McGill M, Farquharson MA: Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: Macrophages, lymphocytes and interferon-γ containing cells. J Pathol 1991;165:97-103.
10. Conrad B, Weldmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-355.
11. Westermann J, Pabst R: Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol Today 1990;11:406-410.
12. Galluzzo A, Giordano C, Rubino G, Bompiani GD: Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin dependent) diabetes mellitus. Diabetologia 1984;26:426-430.
13. Scheinin T, Mäenpää J, Koskimies S, Dean BM, Bottazzo GF, Kontianen S: Insulin responses and lymphocyte subclasses in children with newly diagnosed insulin-dependent diabetes. Clin Exp Immunol 1988;71:91-95.
14. Buschard K, Röpke C, Madsbad S, Mehlsen J, Rygaard J: T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia 1983;25:247-251.
15. Quiniou-Debrie MC, Debray-Sachs M, Dardenne M, Czernichow P, Assan R, Bach JF: Anti-islet cellular and humoral autoimmunity, T-cell subsets, and thymic function in type 1 diabetes. Diabetes 1985;34:373-379.
16. Buschard K, Damsbo P, Röpke C: Activated CD4+ and CD8+ T-lymphocytes in newly diagnosed type 1 diabetes: A prospective study. Diabetic Med 1990;7:132-136.
17. Herold KC, Huen A, Gould L, Traisman H, Rubenstein AH: Alterations in lymphocyte subpopulations in type 1 (insulin dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia 1984;27:102-105.
18. Ilonen J, Surcel HM, Kaa M-L: Abnormalities within CD4 and CD8 T lymphocyte subsets in type 1 (insulin dependent) diabetes. Clin Exp Immunol 1991;85:278-281.
19. Rodier M, Andary M, Richard JL, Mirouze J, Clot J: Peripheral blood T-cell subsets studied by monoclonal antibodies in type 1 (insulin-dependent) diabetes: effect of blood glucose control. Diabetologia 1984;27:136-138.
20. Pontesilli O, Chase HP, Carotenuto P, Herberger MJ, Hayward AR: T-lymphocyte subpopulations in insulin-dependent diabetes mellitus. Clin Exp Immunol 1982;63:68-72.
21. Johnston C, Alviggi L, Millward BA, Leslie RDG, Pyke DA, Vergani D: Alterations in T-lymphocyte subpopulations in type 1 diabetes: Exploration of genetic influence in identical twins. Diabetes 1988;37:1484-1488.
22. Cooke A: Mechanisms of autoimmunity. Diabetic Med 1988;5:782-788.
23. Jackson RA, Morris MA, Haynes BF, Eisenbarth GS: Increased circulating Ia-antigen bearing T cells in type I diabetes mellitus. N Engl J Med 1982;306:785-788.
24. Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PCL, Kyner JL, Cudworth AG: Monoclonal antibodies defined abnormalities of T-lymphocytes in type 1 (insulin-dependent) diabetes. Diabetes 1983;32:91-94.
25. Alviggi L, Johnston C, Hoskins PJ, Tee DEH, Pyke DA, Leslie RDG, Vergani D: Pathogenesis of insulin dependent diabetes: a role for activated T lymphocytes. Lancet 1984;ii:4-5.
26. Peakman M, Hussain MJ, Millward BA, Leslie RDG, Vergani D: Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 (insulin dependent) diabetes. Diabetic Med 1990;7:327-330.
27. 27a Tun RYM, Peakman M, Alviggi L, Hussain MJ, Lo SSS, Shattock M, Pyke DA, Bottazzo GF, Vergani D, Leslie RDG: The importance of persistent cellular and humoral immune changes in the prediabetic period: A prospective identical twin study. Br Med J 1994;308:1063-1068.
28. 27b Peakman M, Leslie RDG, Alviggi L, Hawa M, Verani D: Persistent activation of CD8+ T cells characterizes prediabetic twins. Diabetes Care 1996;19:1177-1184.
29. Peakman M, Leslie RDG, Vergani D: Immunological studies on type 1 diabetes in identical twins. Arch Dis Child 1993;69:97-99.
30. De Berardinis P, Londei M, Kahan M, Balsano F, Kontianen S, Gale EAM, Bottazzo GF, Feldmann M: The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol 1988;73:255-259.
31. Smerdon RA, Peakman M, Hussain MJ, Alviggi L, Watkins PJ, Leslie RDG, Vergani D: Increase in simultaneous co-expression of naive and memory lymphocyte markers at diagnosis of insulin dependent diabetes mellitus. Diabetes 1993;42:127-133.
32. Faustman D, Eisenbarth GS, Daley J, Breitmeyer J: Abnormal T-lymphocyte subsets in type 1 diabetes. Diabetes 1989;38:1462-1468.
33. Chatenoud L, Volpini W, Timsit J, Boitard C, Bach J-F: Aberrant distribution of CD4 and CD8 lymphocyte subsets in recent-onset IDDM patients: effects of cyclosporin. Diabetes 1993;42:869-875.
34. Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF: Selective loss of the suppressor-inducer T cell subset in progressive multiple sclerosis: Analysis with anti-2H4 monoclonal antibody. N Engl J Med 1987;316:67-73.
35. Emery P, Gentry KC, Mackay IR, Muirden KD, Rowley M: Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987;30:849-856.
36. Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987;79:762-763.
37. Castaño L, Eisenbarth GS: Type 1 diabetes: A chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 1990;8:647-649.
38. Peakman M, Alviggi L, Hussain MJ, Lo SSS, Hawa M, Leslie RDG, Vergani D: Increased expression of T cell markers of immunological memory in type 1 diabetes: A study of identical twins. Diabetes 1994;43:712-717.
39. Olmos P, A'Hern R, Heaton DA, Millward BA, Risley D, Pyke DA, Leslie RDG: The significance of the corcordance rate for Type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988;31:747-750.
40. Peakman M, Warnock T, Vats A, McNab GL, Underhill JA, Donaldson PT, Vergani D: Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 diabetes and their first degree relatives. Diabetologia 1994;37:155-165.
41. Thomas ML: The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-369.
42. Clement LT, Yamashito N, Martin AM: The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988;141:1464-1470.
43. Birkeland ML, Johnson P, Trowbridge IS, Pure E: Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci USA 1989;86:6734-6738.
44. Bell EB, Sparshott SM: Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1991;348:163-166.
45. Sanders ME, Makgoba MW, Shaw S: Human naïve and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988;9:195-199.
46. Sanders ME, Makgoba MW, Shaw S: Alterations in T cell subsets in multiple sclerosis and other autoimmune diseases. Lancet 1988;ii:1021.
47. Beverley PCL: Is T-cell memory maintained by cross-reactive stimulation? Immunol Today 1990;11:203-205.
48. Akbar AN, Salmon M, Janossy G: The synergy between naïve and memory T cells during activation. Immunol Today 1991;12:184-188.
49. Michie C, McLean A, Alcock C, Beverley PCL: Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992;360:264-265.
50. Lamb JR, O'Hehir RE, Young DB: The use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes. J Immunol Methods 1988;110:1-10.
51. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL: T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 1988;140:2569-2578.
52. Keller RJ: Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmun 1990;3:321-327.
53. Harrison LC, Chu SX, DeAizpura H, Graham M, Honeyman MC, Colman PG: Islet-reactive T cells are a marker of preclinical insulin dependent diabetes. J Clin Invest 1992;89:1161-1165.
54. Harrison LC, DeAizpura H, Loudovaris T, Campbell IC, Cebon JS, Tait BD, Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin dependent diabetes. Diabetes 1991;40:1128-1133.
55. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-156.
56. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992:339:458-459.
57. Harrison LC, Honeyman MC, DeAizpura HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993;341:1365-1368.
58. Hussain MJ, Peakman M, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of type 1 (insulin-dependent) diabetes. Diabetologia 1996;39:60-69.
59. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M: Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 1994;343:1607-1608.
60. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-2129.
61. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995;181:1957-1963.
62. Baum H, Davies H, Peakman M: Molecular mimicry in the MHC: Hidden clues to autoimmunity? Immunol Today, in press.
63. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo Y-LS, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Leiter EH, Eisenbarth GS: Islet cell autoantigen 69 kD (ICA69): Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993;92:359-371.
64. Castaño L, Russo E, Zhou L, Lipes MA, Eisenbarth GS: Identification and cloning of a granule autoantigen (carboxypeptidase H) associated with type 1 diabetes. J Clin Endocrinol Metab 1991;73:1197-1201.
65. Karounos DG, Thomas JW: Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes 1990;39:1085-1090.
66. r tryptic fragments of islet antigens in insulin dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995;96:1506-1511.
67. Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, De Vries RRP: Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 1989;19:213-216.
68. Roep BO, Aarden SD, De Vries RRP, Hutton JC: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990;345:632-634.
69. Roep BO, Kallan AA, Hazenbos WL, Bruining GJ, Bailyes WM, Aarden SD, Hutton JC, de Vries RR: T-cell reactivity to 38 kD insulin-secretory granule protein in patients with recent-onset type 1 diabetes. Lancet 1991;337:1439-1441.
70. Roep BO, Kallan AA, Duinkerken G, Aarden SD, Hutton JC, Bruining GJ, de Vries RR: T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 1995;44:278-283.
71. Roep BO, Kallan AA, De Vries RRP: β-Cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly-diagnosed IDDM patient. Diabetes 1992;41:1380-1384.
72. Honeyman MC, Cran DS, Harrison LC: Transcription factor jun-B is target of autoreactive T cells in IDDM. Diabetes 1993;42:626-630.
73. Peakman M, Wen L, McNab GL, Watkins PJ, Tan KC, Vergani D: T cell clones generated from patients with Type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity 1994;17:31-39.
74. Kontiainen S, James RFL, Feldmann M: Human islet cell indiced T cell lines and clones from diabetic children. Autoimmunity 1991;8:193-197.
75. Huang GC, Tremble J, Bailyes E, Arden SD, Kaye T, McGregor AM, Banga JP: HLA-DR restricted T cell lines from newly-diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: Lack of reactivity to glutamic acid decarboxylase. Clin Exp Immunol, in press.
76. Panina-Bordigon, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995;181:1923-1927.
77. Vives-Pi M, Somoza N, Vargas P, Armengol Y, Sarri Y, Wu J, Pujol-Borrell R: Expression of glutamic acid decarboxylase (GAD) in the α, β, and δ cells of normal and diabetic pancreas: implications for the pathogenesis of type 1 diabetes. Clin Exp Immunol 1993;92:3916.
78. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AE, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dyrberg T, Lernmark A, Madsen OD, Michelsen BK: Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 1993;42:484-495.
79. Peakman M, Vergani D: Autoimmune disease: Aetiology, therapy and regeneration. Immunol Today 1994;15:345-347.
80. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ: Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283-292.
81. Szopa TM, Titchener PA, Portwood ND, Taylor KW: Diabetes mellitus due to viruses: Some recent developments. Diabetologia 1993;36:687-695.
82. Wucherpfennig KW, Strominger JL: Molecular mimicry in T cell-mediated antoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
83. Von Boehmer H: Positive selection of lymphocytes. Cell 1994;76:219-228.
84. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993;178:27-47.
85. Baum H, Brusic V, Choudhuri K, Cunningham P, Vergani D, Peakman M: MHC molecular mimicry in diabetes. Nature Med 1995;1:388.